Allopurinol and the risk of Stevens-Johnson syndrome and toxic epidermal necrolysis

Abstract

Get full access to this article

View all access options for this article.

References

Yap

FBB

Wahiduzzaman

Pubalan

A 4-year retrospective study of Stevens-Johnson syndrome and toxic epidermal necrolysis. Malays J Dermatol 2008; 21:35–9.

Lee

Pang

Thamotharampillai

Allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis. J Am Acad Dermatol 2008; 59:352–3.

Hung

Chung

Liou

HLA-B5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. Proc Natl Acad Sci USA 2005; 102:4134–9.

Kaniwa

Saito

Aihara

HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis. Pharmacogenomics 2008; 9:1617–22.

Singer

Wallace

SL.

The allopurinol hypersensitivity syndrome. Unnecessary morbidity and mortality. Arthritis Rheum 1986; 29:82–7.